MicroRNA biomarkers in colorectal cancer liver metastasis

34Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Liver metastasis is a primary factor of prognosis and long-term survival for patients diagnosed with colorectal cancer (CRC). Colorectal cancer liver metastasis (CRCLM), is a complex biological process involving multiple factors and steps, and its mechanisms are yet to be discovered. In recent years, small noncoding RNAs, especially microRNAs (miRNAs) have been proven to play an important role in tumorigenesis, progression and metastasis in a variety of cancers, including CRC. Increasing evidence suggests that miRNAs, including those from exosomes secreted by tumor cells in circulation, could be used as promising biomarkers in early cancer detection, treatment, and prognosis. In this review, we focus on the functional roles and clinical applications of miRNAs, especially those from circulating exosomes secreted by tumor cells related to CRCLM.

Cite

CITATION STYLE

APA

Huang, S., Tan, X., Huang, Z., Chen, Z., Lin, P., & Fu, S. W. (2018). MicroRNA biomarkers in colorectal cancer liver metastasis. Journal of Cancer, 9(21), 3867–6873. https://doi.org/10.7150/jca.28588

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free